Overview
We remain deeply committed to our research partners, recognizing their invaluable contributions to advancing science, and improving patient outcomes. By fostering open communication, sharing resources, and celebrating joint achievements, we strengthen the foundation of trust and collaboration that drives meaningful progress.
Together, we continue to push boundaries, innovate, and deliver hope to the AHC community.
Current Research Partners:
- Aspartes Pharmaceutical
- Boston Children’s Hospital (BCH)
- Broad Institute
- Brown University
- Case Western Reserve University
- Child Neurology Foundation
- Global Genes
- Harvard University
- International AHC Research Consortium
- Jackson Laboratories
- Leiden University (The Netherlands)
- Massachusetts General Hospital
- Mahzi Therapeutics
- National Institute of Neurological Disorders and Stroke
- National Organization for Rare Disorders (NORD)
- Northwestern University
- Orphan Disease Center
- RareX
- Rare Epilepsy Network (REN)
- Sorbonne University (France)
We are deeply grateful for the meaningful collaborations we have shared with our earlier research partners. Their dedication, insight, and shared commitment to advancing knowledge have left a lasting impact on the AHC community. These partnerships laid the groundwork for innovation and progress, and we continue to value the contributions they made to our collective mission.
- AxosLabs
- Cleveland Clinic
- Duke University
- Fluofarma IHC
- Janvier Labs (France)
- Montreal Research Symposium (Canada)
- Porsolt (France)
- Radboud University Nijmegen (The Netherlands)
- Seattle Research Symposium
- SomaLogic
- The Jackson Laboratories
- University of Leeds (England)
- University of Seattle
- University of Utah
- UT Southwestern Medical Center
- Vanderbilt University
- Wayne State University